The home shipments — which will be fulfilled by CenterWell Pharmacy — include Wegovy injections of 0.25 mg, 0.5 mg, 1 mg, 1.7 ...
The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic ... called GLP-1 (glucagon-like peptide-1) receptor agonists.
"Demand for the medications Mounjaro, Zepbound, Ozempic, and Wegovy (GLP-1 drugs) has skyrocketed, but supply shortages and high costs have created opportunities for wrongdoers to cash in and ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in ... president of Novo Nordisk Inc., said in a statement Friday. GLP-1 drugs had been in shortage since 2022 due ...